Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral Camostat in Early Ambulatory COVID-19
NCT04625114Phase 2Terminated
- Sponsor
- Ghent University Hospital
- Start
- Nov 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of camostat mesilate in coronavirus disease 2019 (COVID-19), sponsored by Ghent University Hospital. Started Nov 2020; status: terminated.
02
Drugs
camostat mesilate
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04625114.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04625114.